Why the study?
True cardiac etiologies represent only 1%–2.5% of pediatric ED chest pain visits, creating a challenge in distinguishing rare, potentially life-threatening conditions from the majority with benign causes while avoiding unnecessary testing and radiation exposure.
Population
Children and adolescents with chest pain in the emergency department
Design
State-of-the-art narrative review
Answers are grounded in this paper and cite their sources.
Narrative review reveals that true cardiac disease is rare in pediatric chest pain, indicating standardized pathways safely reduce unnecessary testing and radiation exposure.
Background Chest pain accounts for approximately 0.5%–1% of pediatric emergency department (ED) visits and is a frequent source of anxiety for families and clinicians. Although concern for cardiac disease often drives evaluation, true cardiac etiologies are rare, typically representing only 1%–2.5% of cases. The challenge in pediatric emergency care lies in distinguishing the small subset of patients with potentially life‐threatening conditions from the large majority with benign causes, while avoiding unnecessary testing and radiation exposure. Methods We conducted a state‐of‐the‐art narrative review synthesizing contemporary literature on the epidemiology, differential diagnosis, cardiac risk stratification, diagnostic testing, and emerging technologies relevant to pediatric chest pain evaluation in the ED. Emphasis was placed on structured clinical assessment and evidence‐based use of diagnostic modalities. Results Most pediatric chest pain is noncardiac, with musculoskeletal causes predominating, followed by psychogenic, pulmonary, and gastrointestinal etiologies. Cardiac causes remain uncommon but require systematic identification through careful history, focused physical examination, and electrocardiography. High‐risk features include exertional pain, syncope, abnormal examination findings, concerning family history, and abnormal ECG results. Standardized clinical pathways reduce unnecessary imaging and cardiac testing without compromising diagnostic safety. Chest radiography and troponin testing have limited utility when used indiscriminately, whereas point‐of‐care ultrasound offers a radiation‐free adjunct in selected cases. Emerging tools such as teletriage and artificial intelligence–assisted diagnostics show promise but require further validation in pediatric populations. Conclusion Pediatric chest pain is usually benign but necessitates structured, risk‐stratified evaluation to safely exclude serious disease. Judicious testing guided by clinical assessment improves efficiency, minimizes radiation exposure, and supports high‐value, patient‐centered emergency care.
No takes yet. Share an insight, caveat, or question.
Rath et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: